维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="ROMIEU G"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Concurrent or sequential acljuvant letrozole and rauio therapy cofter conservative surgery for ecrly 2 stagel breast cancer(CO2HO2RT):a phase 2 ranclonised trizal显示文摘	Azria D Belkacemi Y Romieu G	2010	Lancet Oncal2010，11，3：	1
2	PhaseⅢStudy of GemcitabinePlus Docetaxel Compared With Capecitabine Plus Docetaxel for An-thracycline Pretreated Patients With Metastatic Breast Cancer显示文摘	Chan S Romieu G Huober Jens	2009	Journal of Clinical Oncology2009，27，11：	1
3	Quality of life assessment in the old using the WHOQOL 100: Differences between patients with senile dementia and patients with cancer 显示文摘	Struttmann T Fabro M Romieu G	1999	Int Psychogeriatr1999，11，3：	1
4	First results of AVEREL,a randomized phase Ⅲ trial to evaluate bevacizumab (BEV) in combination with trastuzumab (H) + docetaxel (DOC) as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)显示文摘	Gianni L Romieu G Lichinitser M		0，，24：	1
5	Phase Ⅲ study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer显示文摘	Chan S Romieu G Huober J	2009	J Clin Oncol2009，27，11：	1
6	Lapatinib plus capecitahine for HER2-positive advanced breast cancer显示文摘	Geyer C E Forster J Lindquist D Chan S Romieu C G Pienkowski T	2006	N Engl J Med2006，355，：	1
7	A dose-finding study of zoledronate in hypercalcemic cancer patients显示文摘	Body JJ Lortholary A Romieu G	1999	J Bone Miner Res1999，14，9：	1
8	Randomized,double-blind,placebo-controlled,phase Ⅲ study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer(mBC):AVADO显示文摘	Miles D Chan A Romieu G	2008	J Clin Oncol2008，26，15：	1
9	Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT):a phase 2 randomised trial显示文摘	Azria D Belkacemi Y Romieu G	2010	Lancet Oncol2010，11，3：	1
10	Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial显示文摘	Romieu G Clemens M Mahlberg R	2007	Crit Rev Oncol Hematol2007，64，1：	1
11	Randomized,double-blind,pla-cebo-controlled,phaseⅢstudy of bevacizumab with docetaxel ordocetaxel with placebo as first-line therapy for patients with locallyrecurrent or metastatic breast cancer(mBC):AVADO显示文摘	Miles D Chan A Romieu G	2008	J ClinOncol2008，26，15：	1
12	Phase III study of gemcitabine plus docetaxel compared with capeeitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer显示文摘	Chan S Romieu G Huober J	2009	J Clin Oncol2009，27，11：	1
13	A dose-finding study of zoledronate in hypercalcemic cancer patients显示文摘	Body JJ Lortholary A Romieu G	1999	J Bone Miner Res1999，14，9：	1
14	Concurrent or equential adju-rant letrozole and radiotherapy after conservative surgery for early- stage breast cancer (CO-HO-RT): a phase 2 randomised trial显示文摘	Azria D Belkacemi Y Romieu G	2010	The Lancet Oncol2010，11，：	1
15	A multicenter randomized phase II study of 4 or 6 cycles of adriamycin/Taxol(paclitaxel) (AT) as neoadjuvant treatment of breast cancer(BC) 显示文摘	Romieu G Tubiana-Hulin M Fumolean P	2002	Ann Oncol2002，13，5：	1
16	Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases:data from the EFECT trial 显示文摘	Mauriac L Romieu G Bines J	2009	Breast Cancer Res Treat2009，117，1：	1
17	Phase Ⅱ multicenter study of larotaxel (XRP9881),a novel taxoid,in patients with metastatic breast cancer who previously received taxane-based therapy显示文摘	Diéras V Limentani S Romieu G	2008	Ann Oncol2008，19，7：	1
18	Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD显示文摘	Jordi de Batlle Jaume Sauleda Eva Balcells Federico P. Gómez Michelle Méndez Esther Rodriguez Esther Barreiro Jaume J. Ferrer Isabelle Romieu Joaquim Gea Josep M. Antó Judith Garcia-Aymerich	2012	The Journal of Nutritional Biochemistry2012，，7：	1
19	PHARE trial results comparing 6 to 12 months of trastuzumab in adjuvant early breast Cancer显示文摘	Pivot X Romieu G Bonnefoi H	2012	Ann Oncol2012，，9：	1
20	6 months veiBus 12 monthsof adjuvant trastuzumab for patients with HER2 -positive early breastcancer(PHARE) :a randomised phase 3 triaI显示文摘	Pivot X Romieu G Debled M	2013	Landet Oncology2013，14，8：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示